Progyny Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Progyny Inc.
Former names: Auxogyn, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 8090 — Services-Misc Health & Allied Services, NEC
Jurisdiction of incorporation: Delaware
Headquarters city: New York
Headquarters state / province: New York
Headquarters country: United States
Fiscal year end: December
Ticker symbol: PGNY
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001551306
EIN: 27-2220139

Board of directors

Follow this board

Beth C. Seidenberg · Director Overboarded
Since 2023
Cheryl Scott · Director
Since 2023
David J. Schlanger · Director · Executive Chairman
Since 2023
Debra L. Morris · Director
Since 2025
Elizabeth D. Bierbower · Director
Since 2025
Fred E. Cohen · Director Overboarded
Since 2023
Jeffrey G. Park · Director
Since 2023
Kevin K. Gordon · Director
Since 2023
Lloyd H. Dean · Director
Since 2023
Norman Payson · Director
Since 2023
Peter Anevski · Director · CHIEF EXECUTIVE OFFICER
Since 2023
Roger C. Holstein · Director
Since 2023

Chief executives

Peter Anevski · CHIEF EXECUTIVE OFFICER

Dates unknown

Director election results

Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 15 other boards. 12 are in the same sector.

Shared director Other board Same sector

Kyverna Therapeutics Inc. Same sector
via Beth C. Seidenberg and Fred E. Cohen
Atara Biotherapeutics Inc. Same sector
via Beth C. Seidenberg
Biote Corp. Same sector
via Debra L. Morris
CareDx Inc. Same sector
via Fred E. Cohen
Evolent Health Inc
via Cheryl Scott
Intellia Therapeutics Inc. Same sector
via Fred E. Cohen
Latigo Biotherapeutics Inc. Same sector
via Beth C. Seidenberg
McDonald's Corporation
via Lloyd H. Dean
Option Care Health Inc. Same sector
via Elizabeth D. Bierbower
P3 Health Partners Inc. Same sector
via Jeffrey G. Park
Rexford Industrial Realty Inc.
via Debra L. Morris
Sagimet Biosciences Inc. Same sector
via Beth C. Seidenberg
Surgery Partners Inc. Same sector
via Lloyd H. Dean
UroGen Pharma Ltd. Same sector
via Fred E. Cohen
Vera Therapeutics Inc. Same sector
via Beth C. Seidenberg

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $1,931,055; 1 purchase by 1 insider
Sold, last 12 months: $14,440,514; 31 sales by 8 insiders

Date	Insider	Transaction	Shares	Price	Value
Nov 9, 2026	David J. Schlanger Director, Officer (Executive Chairman)	Option exercise	+161,208	$0.91	$146,699
Nov 9, 2026	Peter Anevski Director, Officer (CHIEF EXECUTIVE OFFICER)	Option exercise	+126,204	$0.91	$114,846
Nov 9, 2026	David J. Schlanger Director, Officer (Executive Chairman)	Open-market sale	−161,208	$35.73	$5,759,365
Nov 9, 2026	Peter Anevski Director, Officer (CHIEF EXECUTIVE OFFICER)	Open-market sale	−126,204	$35.73	$4,508,726
Nov 9, 2026	Peter Anevski Director, Officer (CHIEF EXECUTIVE OFFICER)	Open-market sale	−35,104	$35.73	$1,254,115
Nov 5, 2026	Peter Anevski Director, Officer (CHIEF EXECUTIVE OFFICER)	Option exercise	+3,400	$0.91	$3,094
Nov 5, 2026	David J. Schlanger Director, Officer (Executive Chairman)	Option exercise	+3,400	$0.91	$3,094
Nov 5, 2026	Peter Anevski Director, Officer (CHIEF EXECUTIVE OFFICER)	Open-market sale	−3,400	$35.23	$119,774
Nov 5, 2026	David J. Schlanger Director, Officer (Executive Chairman)	Open-market sale	−3,400	$35.22	$119,751
Nov 5, 2026	Peter Anevski Director, Officer (CHIEF EXECUTIVE OFFICER)	Open-market sale	−8,539	$35.09	$299,639
Nov 4, 2026	Livingston Mark S. Officer (CHIEF FINANCIAL OFFICER)	Open-market sale	−2,139	$30.00	$64,170
Nov 2, 2026	Swartz Allison Officer (EVP, GC)	Grant or award	+8,160	—	—
Oct 14, 2026	Cummings Melissa B Officer (Chief Operating Officer)	Shares withheld for tax	−1,559	$27.39	$42,701
Oct 14, 2026	Cummings Melissa B Officer (Chief Operating Officer)	Open-market sale	−1,879	$28.00	$52,612
Sep 23, 2026	Swartz Allison Officer (EVP, GC)	Open-market sale	−3,903	$26.10	$101,868

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Progyny Inc.

Who is the CEO of Progyny Inc.?

Peter Anevski is Progyny Inc.'s CHIEF EXECUTIVE OFFICER.

How many directors are on Progyny Inc.'s board?

Progyny Inc.'s board has 12 directors: Beth C. Seidenberg, Cheryl Scott, David J. Schlanger, Debra L. Morris, Elizabeth D. Bierbower, Fred E. Cohen, Jeffrey G. Park, Kevin K. Gordon, Lloyd H. Dean, Norman Payson and 2 others.

Are Progyny Inc. insiders buying or selling shares?

Over the last 12 months, Progyny Inc. insiders bought $1.9 million of shares in 1 purchase and sold $14.4 million of shares in 31 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Progyny Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="progyny-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.